Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3772)
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
10,500
Price
$42.86
Total Value
$450.01K
Shares Held After
154,194
% of Holdings
6.4%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
32,550
Price
$42.07
Total Value
$1.37M
Shares Held After
164,694
% of Holdings
16.5%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
1,000
Price
$40.78
Total Value
$40.78K
Shares Held After
197,244
% of Holdings
0.5%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
85,918
Price
$44.86
Total Value
$3.85M
Shares Held After
2,469,959
% of Holdings
3.4%
IDEAYA Biosciences, Inc. (IDYA)
Ruiz Briseno Andres — Chief Accounting Officer
Shares
9,550
Price
$40.01
Total Value
$382.13K
Shares Held After
26,466
% of Holdings
26.5%
Serina Therapeutics, Inc. (SER)
Brannan Stephen K. — Director
Shares
1,000
Price
$2.03
Total Value
$2.03K
Shares Held After
1,000
% of Holdings
100.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
15,810
Price
$2.48
Total Value
$39.21K
Shares Held After
2,684,180
% of Holdings
0.6%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
952
Price
$93.54
Total Value
$89.05K
Shares Held After
3,985
% of Holdings
19.3%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
19,048
Price
$93.11
Total Value
$1.77M
Shares Held After
4,937
% of Holdings
79.4%
PALISADE BIO, INC. (PALI)
Finley John David — Director
Shares
146,798
Price
$2.07
Total Value
$303.34K
Shares Held After
217,555
% of Holdings
40.3%
PALISADE BIO, INC. (PALI)
Jones Mitchell Lawrence — Chief Medical Officer
Shares
51,880
Price
$2.05
Total Value
$106.54K
Shares Held After
94,009
% of Holdings
35.6%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
30,000
Price
$2.03
Total Value
$61.04K
Shares Held After
416,904
% of Holdings
7.2%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
107,429
Price
$0.31
Total Value
$33.30K
Shares Held After
0
% of Holdings
100.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
5,000
Price
$23.61
Total Value
$118.05K
Shares Held After
2,962
% of Holdings
62.8%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
11,665
Price
$23.62
Total Value
$275.53K
Shares Held After
815,054
% of Holdings
1.4%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
49,193
Price
$23.17
Total Value
$1.14M
Shares Held After
826,719
% of Holdings
5.6%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
14,844
Price
$23.62
Total Value
$350.62K
Shares Held After
1,140,150
% of Holdings
1.3%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
62,543
Price
$23.17
Total Value
$1.45M
Shares Held After
1,154,994
% of Holdings
5.1%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
29,587
Price
$23.62
Total Value
$698.84K
Shares Held After
4,069,482
% of Holdings
0.7%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
124,379
Price
$23.17
Total Value
$2.88M
Shares Held After
4,099,069
% of Holdings
2.9%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
9,288
Price
$89.44
Total Value
$830.72K
Shares Held After
60,299
% of Holdings
13.3%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
11,369
Price
$89.03
Total Value
$1.01M
Shares Held After
69,587
% of Holdings
14.0%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
3,956
Price
$87.17
Total Value
$344.84K
Shares Held After
80,956
% of Holdings
4.7%
Relay Therapeutics, Inc. (RLAY)
Patel Sanjiv — Director
Shares
48,199
Price
$19.58
Total Value
$943.74K
Shares Held After
615,898
% of Holdings
7.3%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
27,282
Price
$81.31
Total Value
$2.22M
Shares Held After
780,073
% of Holdings
3.4%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
22,718
Price
$80.48
Total Value
$1.83M
Shares Held After
807,355
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
62
Price
$563.24
Total Value
$34.92K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$562.60
Total Value
$450.08K
Shares Held After
40,575
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
505
Price
$560.49
Total Value
$283.05K
Shares Held After
41,375
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,399
Price
$559.76
Total Value
$1.90M
Shares Held After
41,880
% of Holdings
7.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,875
Price
$558.90
Total Value
$1.05M
Shares Held After
45,279
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,096
Price
$557.78
Total Value
$611.32K
Shares Held After
47,154
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
726
Price
$556.55
Total Value
$404.06K
Shares Held After
48,250
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
596
Price
$555.50
Total Value
$331.08K
Shares Held After
48,976
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
241
Price
$554.36
Total Value
$133.60K
Shares Held After
49,572
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$553.12
Total Value
$110.62K
Shares Held After
49,813
% of Holdings
0.4%
Theravance Biopharma, Inc. (TBPH)
Samaha Eli — 10% Owner
Shares
5,564
Price
$17.17
Total Value
$95.54K
Shares Held After
9,167,489
% of Holdings
0.1%
ProQR Therapeutics N.V. (PRQR)
de Boer Daniel Anton — Director
Shares
150,000
Price
$1.59
Total Value
$238.50K
Shares Held After
150,000
% of Holdings
100.0%
MeiraGTx Holdings plc (MGTX)
Naylor Stuart — CHIEF SCI OFCR, OPHTHALMOLOGY
Shares
25,112
Price
$14.90
Total Value
$374.17K
Shares Held After
640,846
% of Holdings
3.8%
MeiraGTx Holdings plc (MGTX)
Naylor Stuart — CHIEF SCI OFCR, OPHTHALMOLOGY
Shares
2,547
Price
$13.86
Total Value
$35.30K
Shares Held After
665,958
% of Holdings
0.4%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — Director
Shares
4,200
Price
$36.13
Total Value
$151.76K
Shares Held After
84,040
% of Holdings
4.8%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
50,000
Price
$119.00
Total Value
$5.95M
Shares Held After
666,568
% of Holdings
7.0%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
16,906
Price
$24.20
Total Value
$409.13K
Shares Held After
108,504
% of Holdings
13.5%
Eton Pharmaceuticals, Inc. (ETON)
Opaleye Management Inc. — 10% Owner
Shares
6,685
Price
$38.37
Total Value
$256.52K
Shares Held After
53,315
% of Holdings
11.1%
Eton Pharmaceuticals, Inc. (ETON)
Opaleye Management Inc. — 10% Owner
Shares
20,000
Price
$38.37
Total Value
$767.46K
Shares Held After
2,680,000
% of Holdings
0.7%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$86.62
Total Value
$303.17K
Shares Held After
153,902
% of Holdings
2.2%
Xeris Biopharma Holdings, Inc. (XERS)
Pieper Steven — Chief Financial Officer
Shares
27,600
Price
$8.52
Total Value
$235.28K
Shares Held After
1,366,053
% of Holdings
2.0%
PUMA BIOTECHNOLOGY, INC. (PBYI)
HUNT DOUGLAS M — The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.
Shares
8,460
Price
$8.26
Total Value
$69.90K
Shares Held After
196,841
% of Holdings
4.1%
PUMA BIOTECHNOLOGY, INC. (PBYI)
NOUGUES MAXIMO F — Chief Financial Officer
Shares
9,386
Price
$8.26
Total Value
$77.56K
Shares Held After
230,637
% of Holdings
3.9%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
27,062
Price
$2.49
Total Value
$67.38K
Shares Held After
2,668,370
% of Holdings
1.0%
Showing 351–400 of 3772 transactions (page 8 of 76)